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Background: Chronic illness is a significant driver of the global burden of disease and associated health care costs.
People living with severe chronic illness are heavy users of acute hospital services; better coordination of their care
could potentially improve health outcomes while reducing hospital use. The Care Navigation trial will evaluate an
in-hospital coordinated care intervention on health service use and quality of life in chronically ill patients.
Methods/Design: A randomised controlled trial in 500 chronically ill patients presenting to the emergency
department of a hospital in Western Sydney, Australia. Participants have three or more hospital admissions within a
previous 12 month period and either aged ≥70 years; or aged ≥45 years and of Aboriginal or Torres Strait Islander
descent; or aged ≥ 16 with a diagnosis of a respiratory or cardiology related illness. Patients are randomised to
either the coordinated care program (Care Navigation), or to usual care. The Care Navigation program consists of
dedicated nurses who conduct patient risk assessments, oversee patient nursing while in hospital, and guide
development of a care plan for the management of chronic illness after being discharged from hospital. These
nurses also book community appointments and liaise with general practitioners. The main outcome variables are
the number of emergency department re-presentations and hospital readmissions, and quality of life during a
24 month follow-up. Secondary outcomes are length of hospital stay, mortality, time to first hospital re-admission,
time to first emergency department re-presentation, patient satisfaction, adherence to prescribed medications,
amount and type of in-hospital referrals made for consultations and diagnostic testing, and the number and type
of community health referrals. A process evaluation and economic analysis will be conducted alongside the
randomised trial.
Discussion: A trial of in-hospital care coordination may support recent evidence that engaging primary health
services in care plans linked to multidisciplinary team support improves patient outcomes and reduces costs to the
health system. This will inform local, national and international health policy.
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Chronic illness is a significant contributor to the global
burden of disease, with markedly increasing prevalence and
associated stress on health care systems [1]. In Australia,
80% of the estimated total burden of disease is attributed to
chronic illness, primarily cardiovascular disease, chronic
respiratory conditions, diabetes and cancer [2].
Population ageing exacerbates the burden of chronic
disease in developed countries [2]. Health service needs
for older populations are complex, involving multiple
comorbidities and a broader range of service providers
[3]. It is estimated that among independently living
Australians, almost half aged 65–74 have five or more
chronic conditions, increasing to 70% of those aged 85
and over [4].
People with multiple chronic illnesses are major con-
sumers of health care services [5], accounting for 70% of
general practice consultations. They are twice as likely to
be admitted to hospital, and stay in hospital dispropor-
tionately longer [2]. The substantial cost to government is
further challenged by the need to strengthen disease
prevention initiatives while providing care to a growing
number of patients with chronic disease [6].
High health care costs are driven by the episodic
nature of standard health services, which are focused
around acute care. This model may be poorly structured
and unsupported in the context of patients with chronic
illness who can require multiple presentations across
private medical specialists, community health, general
practice, allied health, and hospital inpatient and out-
patient clinics. International research over the past decade
suggests that chronic illness may be more effectively
treated by better connecting patients’ health management
from hospital to community-based services [2,3,5,7-12].
Coordinated care has been identified as a solution which
provides this link.
The aim of coordinated (or integrated) care is to en-
hance quality of care and quality of life, consumer satis-
faction and system efficiency for patients with complex,
long-term problems across multiple services, providers
and settings [13]. Coordinated care can take on a variety
of forms, but always involves multidisciplinary commu-
nication and care planning [9,14]. Trials to assess the ef-
fectiveness of coordinated care have been conducted
across the OECD, including in Australia, USA, Canada,
England, Italy, Denmark and France [2,3,5,7-12].
A positive effect of community-based care has generally
been shown in trials, with lower rates of hospitalisation
and lower costs [3,8,10]. Improvements in the level of
service access and patient knowledge have also been
observed [2]. However, there is inadequate evaluation of
the outcomes, and particularly the implementation, of
coordinated care interventions within health services.
Within the Australian setting, a randomised controlledtrial (RCT) of the outcomes of face-to-face coordinated
care has not been conducted [2]. More broadly, trials are
often focused on specific conditions or population sub-
groups, and are conducted with small sample sizes and
over short timeframes. In addition, trials conducted to date
employ a highly variable degree of service coordination.
Solid evidence is required of the effectiveness of care
coordination to improve patient outcomes in the popula-
tion. Implementation of care programs must be evaluated
in a way that allows health services to gauge which of its
components (e.g., emergency department, wards, discharge,
community practitioners) and which of its stakeholders
(e.g., patients, carers, nurses, doctors, management, policy-
makers) facilitate or create barriers to the effectiveness of
the new interventions.
Study objectives
A randomised control trial (RCT) will be conducted to
measure the impact of an in-hospital coordinated care
intervention, Care Navigation (CN), on health service
use and quality of life in elderly and chronically ill
patients in Western Sydney, Australia. Effectiveness is
based on emergency hospital presentations, hospital
admissions and quality of life over 24 months. An eco-
nomic evaluation examines the cost-effectiveness of CN
against current standard care from the perspective of the
health sector. A process evaluation will also be conducted
to describe the organisational setting and context within
which CN has been developed and implemented.
Methods/Design
Design and study site
The CN study is a single-blind pragmatic RCT of chroni-
cally ill patients presenting to the emergency department
of Nepean Hospital. Patients are randomly assigned to
receive CN (intervention arm) or standard care (control
arm). Recruitment is conducted over 10 months, and the
two trial arms are followed for 24 months.
Nepean Hospital is a tertiary teaching hospital in
Western Sydney, Australia. It provides inpatient and
ambulatory services, and averages 580 overnight beds. In
2009–2010 it provided 28,989 overnight admissions and
19,113 day-only admissions. There were 16,562 medical
emergency admissions in that year and a total of 51,414
presentations to the emergency department [15].
Study participants
The study includes patients identified by an inclusion
algorithm implemented within the patient tracking
system of the emergency department, or by clinician
recommendation. The inclusion algorithm identifies
patients who have three or more admissions to a Sydney
West Area Health Service hospital within a previous
12 month period and are either aged ≥70 years; or aged
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descent; or aged ≥ 16 with at least one admission for a
respiratory or cardiology related condition. Patients are
also eligible if a treating clinician determines that a
patient would benefit from receiving CN.
Exclusion criteria are not providing written informed
consent; physical or mental inability to give consent or
participate in follow-up activities (e.g. dementia); previously
received CN; or where language skills prevent question-
naire completion.
Consent and randomisation
Written informed consent is obtained from all patients.
All patients identified by the inclusion screening process
are either a) approached in person by a research officer or
CN nurse to discuss study participation; or b) approached
by telephone, if the patient is identified by the screening
process out of hours. All patients approached by tele-
phone are given a patient information sheet while in the
hospital, and sign a ‘consent to approach’ form, giving
permission for study staff to contact them by telephone.
Randomisation is 1:1 allocation and is conducted
using permuted block design and stratified by age group
(age ≥ 70, or age ≥ 45 for Aboriginal or Torres Strait
islander patients). The randomisation is administered by
an independent body (the NHMRC Clinical Trials
Centre’s Randomisation Service), who are contacted by
telephone for the allocation of each patient to a study
arm. Allocation remains masked until after recruitment to
the study. Once a participant is randomised, the research
officer, the CN nurses and participant are not blinded.
The research assistant collecting participant follow-up
data remains blind to the treatment allocation throughout
the two-year follow-up period. Study statisticians remain
blind to allocation until after statistical analyses are
complete.
Description of the intervention
a) Control arm: current standard care
Patients randomised to current standard care are
directed through the hospital system according to
the symptoms they exhibit on presentation to the
emergency department. This may involve treatment
in the emergency department only, or require
hospitalisation before discharge. Patients could be
linked with hospital and community-based health
care facilities, as may normally occur in the absence
of CN.
b) Intervention arm: Care Navigation
Care Navigation involves Inbound, Inflight and
Outbound care components. The Inbound CN nurse
receives an electronic page and on-screen alert
advising them of an automated referral for a CNconsultation at the time of a patient’s presentation to
the emergency department. A risk assessment tool
to assess the patient’s risk of re-presentation is
performed, and a profile of that patient’s health
needs is developed and stored electronically,
incorporating the patient’s hospital and community
health based record, and the patient’s input. Using
this profile, the Inbound CN nurse collaborates with
emergency medical officers to determine whether
the patient requires admission to hospital, or
community-based health care. The Inflight CN nurse
continues patient care after hospital admission. They
oversee patient nursing and guide development of a
care plan for the management of chronic illness after
being discharged from hospital. Patients are care
coordinated and/or case managed by the Outbound
CN nurse, either from the ward or from the
emergency department. The Outbound CN nurse
collaborates with the patient’s multidisciplinary care
team to ensure the patient is ready and safe for
discharge, develops community-based care plans,
books appointments and contacts general
practitioners (GPs). The Outbound CN nurse also
makes follow-up phone calls to patients. Care plans
are recorded in the patient’s electronic hospital
record, faxed to the patients GP, and are revised and
updated as required at any subsequent acute hospital
presentations and admissions.Study variables
In addition to the inclusion and exclusion criteria, six
types of variables are collected: demographic and other
risk factors, psychosocial, hospital utilisation, community
health utilisation, medication usage, and mortality vari-
ables. Outcome variables are calculated after 12 months
and/or 24 months of follow-up period (Table 1).
The three primary outcome measures are a) the rate
of re-presentations* to the emergency department; b)
the rate of hospital re-admissions*, and c) quality of life.
Secondary outcome measures are the length of hospital
stay, mortality rates, time to first hospital re-admission,
time to first ED re-presentation, hospital key perfor-
mance indicators, patient satisfaction, and adherence to
prescribed medications.
*Includes presentations and admissions to any Western
Sydney or Nepean Blue Mountains Local Health District
hospital.
Study size
A total of 500 patients are recruited for this study. With
an expected 20% loss to follow-up, this results in a final
sample size of 400, giving over 90% power to detect a
20% reduction in hospital admissions at a 5% signifi-
cance level. This effect size is a rate ratio of 0.8 based on
Table 1 Quantitative data collected in the Care Navigation randomised controlled trial




Age, sex, Indigenous status, marital status Electronic report from NSW
Health database
Baseline.
Literacy, language, ethnicity, income, education,
BMI, living arrangements smoking, alcohol, physical

















For each emergency presentation within the follow-up
period: Triage category, arrival date and time, departure
date and time, mode of separation, presenting problem
and diagnosis, UDAG status
Electronic report from NSW
Health database
24 months.
For each hospital admission within the follow-up period:
Arrival date and time, departure date and time, diagnosis
related group (DRG), service related group (SRG), investigations
conducted





For each community referral within the follow-up period:
Referral service type, appointment date and time, treatment
administered, attendance and transport





Clinical service utilisation (MBS) Electronic report from Statistics
Medicare Australia
24 months.




Adherence to medications [19]
Mortality data Date of death Electronic report from the National
Death Index (Australian Institute of
Health and Welfare)
24 months.
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period in the control group, compared to 2.0 in the
intervention group. The study has more than 80% power
to detect a clinically significant difference in ED re-
presentations, since ED presentations are more common
than hospital admissions. A sample size of 400 would
also allow us to detect a mean difference of 10 points on
the EQ-5D scale [16], with approximately 80% power at
a 5% significance level.Statistical analysis
Cox proportional hazards models are used to analyse time
to first ED presentation, time to first readmission and time
to mortality. Readmission rates and length of stay are
analysed using Poisson or Negative Binomial models. EQ-
5D is analysed using analysis of variance, and t-tests for
pairwise comparisons. Baseline characteristics, such as
age, gender and severity of illness are examined. Model
checking of assumptions and good-of fit tests are
conducted for all analyses and further analyses are con-
ducted as required. All analyses are conducted according
to the intention-to-treat principle, and will be conducted
in SAS v9.3.Economic evaluation
The cost of CN on the health system is estimated using
standard economic evaluation methodologies. Costings
include direct intervention and patient level costs related
to hospitalisation and primary care, specialist services
and prescribed medications. The costing of health ser-
vices is based on standard published rates, in particular
the Australian Refined Diagnostics Related Group cost
weights for hospitalisations, Medicare Benefits Schedule
(MBS) charges for medical services and Pharmaceutical
Benefits Schedule (PBS) charges for medications. The
measure of effect is determined using Quality Adjusted
Life Years (QALYs), a measure of life expectancy weighted
by health-related quality of life. Average quality of life over
the follow-up period for each patient is estimated and
weighted by survival to determine QALYs gained post
intervention. Incremental cost per QALY gained is calcu-
lated between the intervention and control groups.Process evaluation
A process evaluation is conducted to describe the orga-
nisational setting and context within which CN is deve-
loped and implemented. Interviews are carried out with
Plant et al. BMC Health Services Research 2013, 13:164 Page 5 of 6
http://www.biomedcentral.com/1472-6963/13/164individuals at several levels of program implementation
using purposive sampling as follows: a) hospital, Local
Health District and NSW Ministry of Health policy and
decision makers; b) Nepean Hospital staff in key roles to
explore details and processes of CN, as well as barriers
and facilitators to its implementation; c) clinical staff with
daily indirect involvement with CN to provide broader
organizational context; and d) patients in the intervention
arm, focusing on their experience of chronic illness and its
management as a result of CN. Paired interviews are
carried out with patients, their carers, and also the
patient’s GP, where possible.
All interviews are recorded and transcribed verbatim.
Analysis is thematic, and NVivo v9 is used to assist with
data management. Coding is carried out inductively
based on the themes that emerge from interviews.Ethics
Ethics approval was received from Sydney West Area
Health Service Human Research Ethics Committee –
Nepean Campus [AU RED: HREC/09/NEPEAN/55], now
Nepean Blue Mountains Local Health District Human
Research Ethics Committee.Discussion
To our knowledge, this is the first study to provide a
mixed-method evaluation of the implementation and
effectiveness of a care coordination program in Australia
that includes a heterologous population and substantial
follow-up period. Evidence of any improved patient
outcomes and satisfaction due to care coordination are
critical, given recent interest by governments. Coordi-
nated care is becoming incorporated at the national
policy level in several countries [11,12,17]. The inte-
gration and continuity of prevention and care is a prior-
ity action area in the National Chronic Disease Strategy
of Australia [17]. These policy initiatives must be under-
scored by a solid evidence-base.
The main strengths of this study are the nature of the
CN intervention, the comprehensive process evaluation,
and the design of the RCT. The quantitative compo-
nents of the study utilise a pragmatic RCT, allowing
heterologous patient groups to be randomised to receive
interventions that can be tailored to individual patients
based on type, complexity and severity of disease, while
still providing statistically meaningful information. The
intervention identifies patients in the acute setting with
a single point of access, involves GPs, builds capacity
within the ED, and places the patient at the centre of
decision making using a systems approach to the deli-
very of health care. A patient-centred focus is essential
to ensure the health care and social needs of the popula-
tion are adequately met [5,7].The CN process evaluation provides qualitative data to
complement outcome measures collected by the trial. If
significant changes in patient and health service out-
comes are observed, the process evaluation describes the
mechanisms underpinning these changes. An account of
the implementation of the intervention, and the context
of the health system it is conducted within, gives a richer
understanding of the intervention and enhances the
external validity of the RCT.
The design of the RCT incorporates a large sample
size with adequate power to detect the primary outcomes,
and a long follow-up period to observe meaningful
improvements in patient health outcomes [18,19]. The use
of independent random assignment to the intervention,
blinding where feasible, and an intention to treat analysis
minimises bias.
The main challenges of the intervention are loss to
follow-up, heterogeneity of the intervention received
between patients, and bias in patient recruitment. Loss
to follow-up is minimised by receiving consent at base-
line for hospital, medication and death data to be
obtained electronically from local and national health
databases for the entire follow-up period. Patients are
also in regular contact with CN nurses during the period
of follow-up to action care plans, however, follow-up data
collection is not conducted by CN nurses to minimise
bias. The intervention is conducted with consistent
protocols to minimise between-patient variability. Care
Navigation nurses are trained in these protocols, and
intervention delivery checklists are used to record inter-
vention delivery to the patients. To minimise bias in
patient recruitment, eligibility criteria are designed to
capture all patients who would normally receive CN upon
presentation to the emergency department, while still
maintaining accuracy and completeness of the data.
Efforts are made to accommodate culturally and linguis-
tically diverse patients.
This mixed-methods study informs the generalisability
and sustainability of care coordination programs in
Australia and internationally. The CN trial aims to build
upon these principles to provide a comprehensive coor-
dinated care program for improving health outcomes
among patients with chronic illness.
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